Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

9 results
Display

Neuroscience-based Nomenclature (NbN) for Clinical Psychopharmacology and Neuroscience

Uchida H, Yamawaki S, Bahk WM, Jon DI

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factor Structure of the Targeted Inventory on Problems in Schizophrenia

Tanaka S, Nagase T, Suzuki T, Nomura K, Takeuchi H, Nakajima S, Uchida H, Yagi G, Watanabe K, Mimura M

  • KMID: 2171192
  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):18-23.
OBJECTIVE: The aim of this study was to explore the factor structure of a novel, 10-item rating scale, the Targeted Inventory on Problems in Schizophrenia (TIP-Sz). Determining the factor structure...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The extracorporeal circulation with transdiaphragmatic approach in living-donor liver transplantation for hepatoblastoma with atrial extension of tumor thrombus

Kasahara M, Sakamoto S, Yanagi Y, Uchida H, Shimizu S, Mimori K, Kameoka Y, Fukuda A

Background: Surgical intervention for hepatoblastoma (HB) with tumor thrombi extending into the inferior vena cava (IVC) and the right atrium (RA) might require careful planning of the surgical procedures, including...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reconsideration of pathology and management for acute antibodymediated rejection in pediatric ABO incompatible transplantation

Yanagi Y, Sakamoto S, Mimori K, Nakao M, Shimizu S, Uchida H, Fukuda A, Kasahara M

Background: The management and outcome of ABO incompatible liver transplantation (ABO-I LT) has been improved in the decades. Recently, latest pathological evaluation of acute antibody-mediated rejection (AMR) was introduced through...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The impact of COVID-19 on pediatric liver transplantation recipients in National Center for Child Health and Development

Shimizu S, Sakamoto S, Yamada M, Uchida H, Okada N, Nakao O, Kodama T, Komine R, Fukuda A, Kasahara M

Background: Patients with immunosuppression are reported to be at a high risk of severe and prolonged COVID-19. However, there is insufficient evidence of the clinical significance of COVID-19 and the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series

Tani H, Tomita M, Suzuki T, Mimura M, Uchida H

Objective: While antipsychotics are necessary for relapse prevention in the treatment of schizophrenia in general, some minority of patients may be maintained without continuous antipsychotic treatment. However, the characteristics of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intraoperative aborted living donor liver transplantation surgeries, lessons from 13,937 cases of Vanguard multi-center study of international living donor liver transplantation group

Toshima T, Lee KW, Rhu J, Yoon YI, Ito T, Uchida H, Hong SK, Reddy MS, Ikegami T, Yoshizumi T

Background: We rarely experience these situations where intraoperative abortions are inevitable in living donor liver transplan-tation (LDLT) by unexpected or catastrophic events in the real world. To date, there has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The impact of donor-specific alloantibodies on chronic antibodymediated rejection after pediatric living donor liver transplantation

Shimizu S, Sakamoto S, Fukuda A, Yanagi Y, Uchida H, Mimori K, Nakao T, Yamada M, Yoshioka T, Kasahara M

Background: The development of anti-human leukocyte antigen donor-specific alloantibodies (DSA) after living donor liver transplantation (LDLT) can lead to chronic antibody-mediated rejection (cAMR). This study aimed to analyze the detail...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vascular reconstruction and long-term outcome of living domino liver transplantation in children

Shimizu S, Sakamoto S, Kameoka Y, Mimori K, Uchida H, Yanagi Y, Fukuda A, Horikawa R, Kasahara M

Background: A native liver of maple syrup urine disease (MSUD) patients can be used as a graft to non-MSUD patients with endstage liver disease because an extrahepatic enzyme activity can...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr